227 related articles for article (PubMed ID: 34014468)
21. C/EBPα-induced miR-100 expression suppresses tumor metastasis and growth by targeting ZBTB7A in gastric cancer.
Shi DB; Wang YW; Xing AY; Gao JW; Zhang H; Guo XY; Gao P
Cancer Lett; 2015 Dec; 369(2):376-85. PubMed ID: 26404754
[TBL] [Abstract][Full Text] [Related]
22. Gene amplification is a relatively frequent event leading to ZBTB7A (Pokemon) overexpression in non-small cell lung cancer.
Apostolopoulou K; Pateras IS; Evangelou K; Tsantoulis PK; Liontos M; Kittas C; Tiniakos DG; Kotsinas A; Cordon-Cardo C; Gorgoulis VG
J Pathol; 2007 Nov; 213(3):294-302. PubMed ID: 17907153
[TBL] [Abstract][Full Text] [Related]
23. A Zbtb7a proto-oncogene as a novel target for miR-125a.
Hojo N; Tatsumi N; Moriguchi N; Matsumura A; Morimoto S; Nakata J; Fujiki F; Nishida S; Nakajima H; Tsuboi A; Oka Y; Hosen N; Hayashi S; Sugiyama H; Oji Y
Mol Carcinog; 2016 Dec; 55(12):2001-2009. PubMed ID: 26713860
[TBL] [Abstract][Full Text] [Related]
24. Low nuclear zinc finger and BTB domain containing 7A expression is an independent prognostic factor for recurrence-free survival in invasive ductal carcinoma of the breast.
Kim Y; Kim HS; Do SI
Int J Clin Exp Pathol; 2018; 11(4):2193-2200. PubMed ID: 31938331
[TBL] [Abstract][Full Text] [Related]
25. ZBTB7A, a miR-144-3p targeted gene, accelerates bladder cancer progression via downregulating HIC1 expression.
Liu J; Chou Z; Li C; Huang K; Wang X; Li X; Han C; Al-Danakh A; Li X; Song X
Cancer Cell Int; 2022 May; 22(1):179. PubMed ID: 35501800
[TBL] [Abstract][Full Text] [Related]
26. ZBTB7A Enhances Osteosarcoma Chemoresistance by Transcriptionally Repressing lncRNALINC00473-IL24 Activity.
Zhang L; Wang Y; Li X; Xia X; Li N; He R; He H; Han C; Zhao W
Neoplasia; 2017 Nov; 19(11):908-918. PubMed ID: 28942243
[TBL] [Abstract][Full Text] [Related]
27. Zbtb7a suppresses prostate cancer through repression of a Sox9-dependent pathway for cellular senescence bypass and tumor invasion.
Wang G; Lunardi A; Zhang J; Chen Z; Ala U; Webster KA; Tay Y; Gonzalez-Billalabeitia E; Egia A; Shaffer DR; Carver B; Liu XS; Taulli R; Kuo WP; Nardella C; Signoretti S; Cordon-Cardo C; Gerald WL; Pandolfi PP
Nat Genet; 2013 Jul; 45(7):739-746. PubMed ID: 23727861
[TBL] [Abstract][Full Text] [Related]
28. Stable knockdown of ZBTB7A promotes cell proliferation and progression in nasopharyngeal carcinoma.
Liu F; Tang F; Lan J; Jiao W; Si Y; Lu W; Mo M; Li B; Lu J; Wei J; Qin Y; Xiao R; Zhang B; Wang Y; Xiong W
Tumori; 2018; 104(1):37-42. PubMed ID: 29699474
[TBL] [Abstract][Full Text] [Related]
29. Knockdown of ZBTB7A inhibits cell proliferation of breast cancer through regulating the ubiquitination of estrogen receptor alpha.
Xiao X; Shen Y; Yin L; He J; Ni X; Luo G; Chen X; Zhu W; Zhong J; Liu J; Peng X; Zu X
Life Sci; 2019 Dec; 239():117042. PubMed ID: 31715186
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-520e suppresses non-small-cell lung cancer cell growth by targeting Zbtb7a-mediated Wnt signaling pathway.
Zhijun Z; Jingkang H
Biochem Biophys Res Commun; 2017 Apr; 486(1):49-56. PubMed ID: 28242196
[TBL] [Abstract][Full Text] [Related]
31. Broad-complex, tramtrack, and bric-à-brac (BTB) proteins: Critical regulators of development.
Chaharbakhshi E; Jemc JC
Genesis; 2016 Oct; 54(10):505-518. PubMed ID: 27521773
[TBL] [Abstract][Full Text] [Related]
32. ZBTB7A mutations in acute myeloid leukaemia with t(8;21) translocation.
Hartmann L; Dutta S; Opatz S; Vosberg S; Reiter K; Leubolt G; Metzeler KH; Herold T; Bamopoulos SA; Bräundl K; Zellmeier E; Ksienzyk B; Konstandin NP; Schneider S; Hopfner KP; Graf A; Krebs S; Blum H; Middeke JM; Stölzel F; Thiede C; Wolf S; Bohlander SK; Preiss C; Chen-Wichmann L; Wichmann C; Sauerland MC; Büchner T; Berdel WE; Wörmann BJ; Braess J; Hiddemann W; Spiekermann K; Greif PA
Nat Commun; 2016 Jun; 7():11733. PubMed ID: 27252013
[TBL] [Abstract][Full Text] [Related]
33. ZBTB7A prevents RUNX1-RUNX1T1-dependent clonal expansion of human hematopoietic stem and progenitor cells.
Redondo Monte E; Wilding A; Leubolt G; Kerbs P; Bagnoli JW; Hartmann L; Hiddemann W; Chen-Wichmann L; Krebs S; Blum H; Cusan M; Vick B; Jeremias I; Enard W; Theurich S; Wichmann C; Greif PA
Oncogene; 2020 Apr; 39(15):3195-3205. PubMed ID: 32115572
[TBL] [Abstract][Full Text] [Related]
34. Sox2: A Regulatory Factor in Tumorigenesis and Metastasis.
Chaudhary S; Islam Z; Mishra V; Rawat S; Ashraf GM; Kolatkar PR
Curr Protein Pept Sci; 2019; 20(6):495-504. PubMed ID: 30907312
[TBL] [Abstract][Full Text] [Related]
35. Hypoxia-induced RelA/p65 derepresses SLC16A3 (MCT4) by downregulating ZBTB7A.
Choi SH; Kim MY; Yoon YS; Koh DI; Kim MK; Cho SY; Kim KS; Hur MW
Biochim Biophys Acta Gene Regul Mech; 2019 Aug; 1862(8):771-785. PubMed ID: 31271899
[TBL] [Abstract][Full Text] [Related]
36. LRF/ZBTB7A conservation accentuates its potential as a therapeutic target for the hematopoietic disorders.
Chondrou V; Markopoulos GS; Patrinos GP; Kouraklis-Symeonidis A; Symeonidis A; Papachatzopoulou A; Sgourou A
Gene; 2020 Nov; 760():145020. PubMed ID: 32755656
[TBL] [Abstract][Full Text] [Related]
37. Functional analysis of the role of POK transcriptional repressors.
Costoya JA
Brief Funct Genomic Proteomic; 2007 Mar; 6(1):8-18. PubMed ID: 17384421
[TBL] [Abstract][Full Text] [Related]
38. Proto-oncogene FBI-1 (Pokemon) and SREBP-1 synergistically activate transcription of fatty-acid synthase gene (FASN).
Choi WI; Jeon BN; Park H; Yoo JY; Kim YS; Koh DI; Kim MH; Kim YR; Lee CE; Kim KS; Osborne TF; Hur MW
J Biol Chem; 2008 Oct; 283(43):29341-54. PubMed ID: 18682402
[TBL] [Abstract][Full Text] [Related]
39. Zbtb7a induction in alveolar macrophages is implicated in anti-HLA-mediated lung allograft rejection.
Nayak DK; Zhou F; Xu M; Huang J; Tsuji M; Yu J; Hachem R; Gelman AE; Bremner RM; Smith MA; Mohanakumar T
Sci Transl Med; 2017 Jul; 9(398):. PubMed ID: 28701473
[TBL] [Abstract][Full Text] [Related]
40. YY1 Is an Inducer of Cancer Metastasis.
Wang W; Li D; Sui G
Crit Rev Oncog; 2017; 22(1-2):1-11. PubMed ID: 29604932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
